Literature DB >> 8605009

Uroguanylin: cloning of preprouroguanylin cDNA, mRNA expression in the intestine and heart and isolation of uroguanylin and prouroguanylin from plasma.

X Fan1, F K Hamra, R H Freeman, S L Eber, W J Krause, R W Lim, V M Pace, M G Currie, L R Forte.   

Abstract

Uroguanylin is a small peptide isolated from opossum urine that activates membrane guanylate cyclases. We report the isolation by molecular cloning of cDNAs encoding the 109 amino acid preprouroguanylin containing the active uroguanylin peptide at its C-terminus. Preprouroguanylin mRNAs of 1.2 kb were detected throughout the small and large intestine and in the atria and ventricles of heart, but not in kidney, stomach or liver. Transfection of COS-1 cells with the uroguanylin cDNA resulted in prouroguanylin secretion. Both uroguanylin and prouroguanylin were isolated from opossum plasma. Thus, uroguanylin is made by the intestine and heart and circulates as a bioactive form of uroguanylin and the inactive prouroguanylin.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8605009     DOI: 10.1006/bbrc.1996.0255

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Regulation of intestinal uroguanylin/guanylin receptor-mediated responses by mucosal acidity.

Authors:  F K Hamra; S L Eber; D T Chin; M G Currie; L R Forte
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

2.  Agonist-specific compartmentation of cGMP action in myometrium.

Authors:  Iain L O Buxton; Deanna Milton; Scott D Barnett; Stephen D Tichenor
Journal:  J Pharmacol Exp Ther       Date:  2010-07-22       Impact factor: 4.030

Review 3.  Zinc and intestinal function.

Authors:  C E Semrad
Journal:  Curr Gastroenterol Rep       Date:  1999-10

4.  The rat kidney contains high levels of prouroguanylin (the uroguanylin precursor) but does not express GC-C (the enteric uroguanylin receptor).

Authors:  Xun Qian; Nicholas G Moss; Robert C Fellner; Bonnie Taylor-Blake; Michael F Goy
Journal:  Am J Physiol Renal Physiol       Date:  2010-11-24

5.  The natriuretic peptide uroguanylin elicits physiologic actions through 2 distinct topoisomers.

Authors:  Nicholas G Moss; Dorothy A Riguera; Robert M Solinga; Marco M Kessler; Daniel P Zimmer; William J Arendshorst; Mark G Currie; Michael F Goy
Journal:  Hypertension       Date:  2009-03-16       Impact factor: 10.190

Review 6.  Pendrin, a novel transcriptional target of the uroguanylin system.

Authors:  Julia Rozenfeld; Osnat Tal; Orly Kladnitsky; Lior Adler; Edna Efrati; Stephen L Carrithers; Seth L Alper; Israel Zelikovic
Journal:  Cell Physiol Biochem       Date:  2013-12-18

7.  Occurrence and localization of uroguanylin in the aging human prostate.

Authors:  Caroline Maake; Franziska Auf der Maur; Katarina Jovanovic; Manfred Reinecke; Dieter Hauri; Hubert John
Journal:  Histochem Cell Biol       Date:  2002-12-21       Impact factor: 4.304

8.  Circulating prouroguanylin is processed to its active natriuretic form exclusively within the renal tubules.

Authors:  Xun Qian; Nicholas G Moss; Robert C Fellner; Michael F Goy
Journal:  Endocrinology       Date:  2008-05-22       Impact factor: 4.736

9.  Uroguanylin, an intestinal natriuretic peptide, is delivered to the kidney as an unprocessed propeptide.

Authors:  Nicholas G Moss; Robert C Fellner; Xun Qian; Sharon J Yu; Zhiping Li; Masamitsu Nakazato; Michael F Goy
Journal:  Endocrinology       Date:  2008-05-22       Impact factor: 4.736

10.  Low salt intake down-regulates the guanylin signaling pathway in rat distal colon.

Authors:  Z Li; J W Knowles; D Goyeau; S Prabhakar; D B Short; A G Perkins; M F Goy
Journal:  Gastroenterology       Date:  1996-12       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.